Survivor Profile Still in the Game ESPN reporter Holly Rowe worked through melanoma treatment. by Lindsey Konkel Q&A Dissecting Mental Illness Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain. by Marci A. Landsmann Pembrolizumab Shows Further Promise for Melanoma In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected. by Brad Jones Forward Look Tackling Drug Resistance Researchers are studing new ways to keep treatments working longer. by Stephen Ornes Survivor Profile Living in the Here and Now A metastatic melanoma survivor is hopeful but realistic as new treatments become available. by Jenny Song Forward Look Cancer Immunotherapies Continue to Make Headway Drugs that harness the power of the immune system gain new approvals. by Alexandra Goho Survivor Profile Knowing Her Options When Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors. by Melissa Davlin First Person Keeping Sight of Hope A survivor keeps an eye on what's ahead after a rare cancer diagnosis. by Sue Russell Forward Look Boosting Defenses Against Cancer Q&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City. by Ingfei Chen Cancer Talk Advocacy Spotlight: A Mission to Bring Awareness Minister and thyroid cancer survivor Thurselle C. Williams speaks at conferences and events about cancer awareness and, ultimately, healing following her 2016 diagnosis. by Erin L. Boyle Do Patients Want Online Access to Test Results? A survey finds many patients prefer talking through imaging findings related to cancer with their physician rather than viewing reports online—but only if the wait for results is short. by Cindy Kuzma Immunotherapy in the Elderly Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group. by Emma Yasinski Why Is the Rate of Uterine Cancer Rising? Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed. by Ashley P. Taylor More Posts